» Articles » PMID: 25374761

Protein Kinases Are Potential Targets to Treat Inflammatory Bowel Disease

Overview
Date 2014 Nov 7
PMID 25374761
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Protein kinases play a crucial role in the pathogenesis of inflammatory bowel disease (IBD), the two main forms of which are ulcerative colitis and Crohn's disease. In this article, we will review the mechanisms of involvement of protein kinases in the pathogenesis of and intervention against IBD, in terms of their effects on genetics, microbiota, mucous layer and tight junction, and the potential of protein kinases as therapeutic targets against IBD.

Citing Articles

Integrating machine learning and structure-based approaches for repurposing potent tyrosine protein kinase Src inhibitors to treat inflammatory disorders.

Iqbal M, Shahab M, Ullah Z, Zheng G, Anjum I, Shazly G Sci Rep. 2025; 15(1):1836.

PMID: 39805859 PMC: 11730308. DOI: 10.1038/s41598-024-83767-9.


Gut barrier-microbiota imbalances in early life lead to higher sensitivity to inflammation in a murine model of C-section delivery.

Barone M, Ramayo-Caldas Y, Estelle J, Tambosco K, Chadi S, Maillard F Microbiome. 2023; 11(1):140.

PMID: 37394428 PMC: 10316582. DOI: 10.1186/s40168-023-01584-0.


Microbiota, not host origin drives intestinal epithelial responses.

Arnauts K, Sudhakar P, Verstockt S, Lapierre C, Potche S, Caenepeel C Gut Microbes. 2022; 14(1):2089003.

PMID: 35758256 PMC: 9235885. DOI: 10.1080/19490976.2022.2089003.


Overview of Immunological Responses and Immunomodulation Properties of sp.: Prospects for Better Understanding Human Trichuriasis.

Darlan D, Rozi M, Yulfi H Life (Basel). 2021; 11(3).

PMID: 33673676 PMC: 7997218. DOI: 10.3390/life11030188.


Computational drug repurposing for inflammatory bowel disease using genetic information.

Grenier L, Hu P Comput Struct Biotechnol J. 2019; 17:127-135.

PMID: 30728920 PMC: 6352300. DOI: 10.1016/j.csbj.2019.01.001.


References
1.
Kong K, Fu G, Zhang Y, Yokosuka T, Casas J, Canonigo-Balancio A . Protein kinase C-η controls CTLA-4-mediated regulatory T cell function. Nat Immunol. 2014; 15(5):465-72. PMC: 4040250. DOI: 10.1038/ni.2866. View

2.
Caruso R, Fina D, Peluso I, Stolfi C, Fantini M, Gioia V . A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells. Gastroenterology. 2007; 132(1):166-75. DOI: 10.1053/j.gastro.2006.09.053. View

3.
Kelly D, Campbell J, King T, Grant G, Jansson E, Coutts A . Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol. 2003; 5(1):104-12. DOI: 10.1038/ni1018. View

4.
Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S . Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007; 446(7135):557-61. DOI: 10.1038/nature05698. View

5.
Zanin-Zhorov A, Ding Y, Kumari S, Attur M, Hippen K, Brown M . Protein kinase C-theta mediates negative feedback on regulatory T cell function. Science. 2010; 328(5976):372-6. PMC: 2905626. DOI: 10.1126/science.1186068. View